Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI110459

Sodium Channel and Sodium Pump in Normal and Pathological Muscles from Patients with Myotonic Muscular Dystrophy and Lower Motor Neuron Impairment

C. Desnuelle, A. Lombet, G. Serratrice, and M. Lazdunski

Centre de Biochimie du Centre National de la Recherche Scientifique, Faculté des Sciences, 06034 Nice Cedex, France

Clinique Rhumatologique et des Maladies Neuro-Musculaires, Centre Hospitalo-Universitaire de la Timone, 13385 Marseille Cedex 4, France

Centre de Biologie Moléculaire du Centre National de la Recherche Scientifique, 13274 Marseille Cedex 2, France

Find articles by Desnuelle, C. in: JCI | PubMed | Google Scholar

Centre de Biochimie du Centre National de la Recherche Scientifique, Faculté des Sciences, 06034 Nice Cedex, France

Clinique Rhumatologique et des Maladies Neuro-Musculaires, Centre Hospitalo-Universitaire de la Timone, 13385 Marseille Cedex 4, France

Centre de Biologie Moléculaire du Centre National de la Recherche Scientifique, 13274 Marseille Cedex 2, France

Find articles by Lombet, A. in: JCI | PubMed | Google Scholar

Centre de Biochimie du Centre National de la Recherche Scientifique, Faculté des Sciences, 06034 Nice Cedex, France

Clinique Rhumatologique et des Maladies Neuro-Musculaires, Centre Hospitalo-Universitaire de la Timone, 13385 Marseille Cedex 4, France

Centre de Biologie Moléculaire du Centre National de la Recherche Scientifique, 13274 Marseille Cedex 2, France

Find articles by Serratrice, G. in: JCI | PubMed | Google Scholar

Centre de Biochimie du Centre National de la Recherche Scientifique, Faculté des Sciences, 06034 Nice Cedex, France

Clinique Rhumatologique et des Maladies Neuro-Musculaires, Centre Hospitalo-Universitaire de la Timone, 13385 Marseille Cedex 4, France

Centre de Biologie Moléculaire du Centre National de la Recherche Scientifique, 13274 Marseille Cedex 2, France

Find articles by Lazdunski, M. in: JCI | PubMed | Google Scholar

Published February 1, 1982 - More info

Published in Volume 69, Issue 2 on February 1, 1982
J Clin Invest. 1982;69(2):358–367. https://doi.org/10.1172/JCI110459.
© 1982 The American Society for Clinical Investigation
Published February 1, 1982 - Version history
View PDF
Abstract

Two sodium transport systems have been analyzed in this work: the voltage-sensitive sodium channel and the (Na+, K+) ATPase pump. The sodium channel has been studied using a tritiated derivative of tetrodotoxin; the sodium pump has been studied using tritiated ouabain. Properties of interaction of tritiated tetrodotoxin and of tritiated ouabain with their respective receptors were observed in normal human skeletal muscle and in muscles of patients with myotonic muscular dystrophy and with lower motor neuron impairment.

Levels of sodium pump and of sodium channels were measured at different stages of membrane purification. Microsomal fractions of normal human muscle have maximal binding capacities for tetrodotoxin of 230 fmol/mg of protein and of 7.4 pmol/mg of protein for ouabain.

Dissociation constant for the complexes formed by the tetrodotoxin derivative and by ouabain with their respective receptors were 0.52 nM and 0.55 μM, respectively.

In muscles from patients with myotonic muscular dystrophy, the maximal binding capacity for tetrodotoxin, i.e., the number of Na+ channels was found to be very similar to that found for normal muscle. The maximal binding capacity for ouabain, i.e., the number of Na+ pumps was three- to sixfold lower than in normal muscle. Dissociation constants for the complexes formed with the tetrodotoxin derivative and with ouabain were the same as for normal muscle.

In muscles from patients with lower motor nerve impairment, the maximal binding capacities for tetrodotoxin and for ouabain were twice as high as in normal muscle. Again, dissociation constants for the complexes formed with the tetrodotoxin derivative and with ouabain were nearly unchanged as compared with normal muscle.

These results suggest that sodium transport systems involved in the generation of action potentials and/or in the regulation of the resting potential are altered both in myotonic muscular dystrophy and in lower motor neuron impairment.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 358
page 358
icon of scanned page 359
page 359
icon of scanned page 360
page 360
icon of scanned page 361
page 361
icon of scanned page 362
page 362
icon of scanned page 363
page 363
icon of scanned page 364
page 364
icon of scanned page 365
page 365
icon of scanned page 366
page 366
icon of scanned page 367
page 367
Version history
  • Version 1 (February 1, 1982): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts